The research team led by Haohao Dong and Xiaodi Tang focuses on bacterial physiology, pathogenicity, infection mechanisms, and antibiotic resistance. Their work includes studying the molecular mechanisms of bacterial outer membrane biosynthesis, membrane stability maintenance, bacterial division, resistance mechanisms, and host infection. The team also conducts biochemical research on novel antimicrobial drug targets, including the screening of target proteins and the design of small molecules and peptides.Using molecular cloning and gene editing as the foundation, and supported by recombinant protein expression and chromatographic purification, the team has established expression systems for bacteria, insects, yeast, and human cells. They carry out expression and in vitro purification experiments on membrane protein complexes from both prokaryotic and eukaryotic organisms. The team utilizes cryo-electron microscopy (cryo-EM) and protein crystallography with X-ray diffraction to analyze multi-conformational complexes of membrane proteins bound to ligands or inhibitors. By reconstructing protein-liposome complexes to simulate biological membrane environments, and combining functional verification techniques such as site-directed mutagenesis, fluorescence probe tracking, and microscopy characterization, the team elucidates the mechanisms of action of target proteins. They also identify key functional domains, providing insights for the development of targeted antimicrobial drugs.
The team’s research has been published in leading academic journals such as Nature (2023, 2016, 2014), Nature Structural & Molecular Biology (2021, 2020), Nature Communications (2019, 2017), PNAS (2023), Cell Discovery (2024), and Signal Transduction and Targeted Therapy (2024). Their work has attracted significant attention from experts worldwide and has been recommended on the Faculty Opinions platform. The team is based at the National Key Laboratory of Biotherapy at West China Hospital, Sichuan University, which is part of the Ministry of Education’s "985 Project" Class I Innovation Platform and one of the first national "2011 Plan" Collaborative Innovation Centers for Biotherapy. The laboratory offers a robust research environment, state-of-the-art facilities, and strong support for applied translation, with key technology platforms covering gene discovery, drug development, and clinical testing. The team looks forward to collaborating with experts in various fields and welcomes talented young researchers to join their efforts!
We sincerely look forward to collaborating with experts from various fields and welcome the addition of young talents to our team!